FDA — authorised 28 November 2025
- Application: BLA761212
- Marketing authorisation holder: LUPIN LTD
- Local brand name: ARMLUPEG
- Indication: INJECTION — SOLUTION
- Status: approved
FDA authorised ARMLUPEG on 28 November 2025
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 28 November 2025.
LUPIN LTD holds the US marketing authorisation.